Use access key #2 to skip to page content.
$19.38 -0.04 (-0.21%)
5/16/2008 4:04 PM

Schering-Plough Corp (SGP)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets medical therapies and treatments to enhance human health.

View All Commentary (SGP)

Recs

0

Avatar Money2themax (61.58) Submitted: 5/07/08 12:28 AM : Underperform Start Price: $18.66 SGP Score: -3.37

This stock is the securities version of a 'pet rock'-- solid but essentially useless. Put that stone's creation at management's door because this company could and SHOULD be a juggernaut.

Barring a surprise drug gaining approval-- this company's performance will remain essentially flat. It will cycle up again to be sure when it's drug pipeline produces something (anything!) that the FDA can approve. But, in the short term to medium term-- hard-earned money is best invested elsewhere.

Report this Post Replies: 0 | Reply

Featured Broker Partners